Ladenburg Thalmann Starts Neurobo Pharmaceuticals (NRBO) at Buy
Tweet
Share
E-mailGet Alerts NRBO Hot Sheet
Price: $2.36 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 17
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 17
Join SI Premium – FREE
Ladenburg Thalmann initiates coverage on Neurobo Pharmaceuticals (NASDAQ: NRBO) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Neurobo Pharmaceuticals click here. For more ratings news on Neurobo Pharmaceuticals click here.
Shares of Neurobo Pharmaceuticals closed at $1.42 yesterday.
You May Also Be Interested In
- Bernstein SocGen Group Starts Americana Restaurants (AMR:UH) at Outperform
- Canaccord Starts Wise plc (WISE:LN) (WSE) at Buy
- Jefferies Starts Almonty Industries (ALM) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
